REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQXT.L Regulatory News (QXT)

  • There is currently no data for QXT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update and Notice of Results

14 Jul 2022 07:00

RNS Number : 3980S
Quixant PLC
14 July 2022
 

The information contained within this announcement is deemed by the Company to constitute inside information pursuant to Article 7 of EU Regulation 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 as amended.

 

14 July 2022

Quixant plc

("Quixant" or the "Group")

Trading Update and Notice of Results

Strong demand drives FY22 revenue and profit upgrade

 

Quixant (AIM:QXT), a leading provider of innovative, highly engineered technology products principally for the global gaming and broadcast industries, is pleased to provide an update on trading for the six months ended 30 June 2022 and outlook for the remainder of 2022.

 

Trading

The strong demand across both Gaming and Densitron businesses seen in 2021 has continued in the first half of 2022, with order intake during the period ahead of first half revenues and prior year bookings.

 

Group revenue for H1 is expected to be $53.3m, 46% up year-on-year and the highest first half revenue performance since 2017, and ahead of management expectations. The recovery in the Gaming division has continued with first half revenues of $31.4m, a 71% increase on the previous year. Densitron is expected to deliver revenue of $21.9m in the first half, 21% up on H1 2021, delivering the strongest half year performance since acquisition in 2015. 

 

Six months ended 30 June 2022

 

Six months ended 30 June 2021

 

Change

 

 

($m)

($m)

 

 

Group Revenue

53.3

36.5

46%

Gaming Division Revenue

31.4

18.4

71%

Densitron Revenue

21.9

 

18.1

 

21%

 

 

 

 

 

 

Supply chain constraints continue to impact the availability of key components but the strategic stock purchase programme, which has been operating since January 2021, has allowed the Group to manage these challenges well and continue to supply product to meet customer demand. We expect this industry-wide issue to persist until at least the first half of 2023. Supply chain issues also continue to lead to component price volatility impacting gross margins, although the Group is seeing early signs of gross margin recovery. The Group is not immune to global inflationary pressures leading to increased operating costs which are being managed, together with making investments to support future growth.

 

The Group's net cash position at 30 June 2022 was $12.0m (31 December 2021: $17.6m), reflecting the Group's continued investment in stock to mitigate the impact of the global supply chain constraints and meet customer demand.

 

 

 

Outlook

Trading in the first half was ahead of management expectations reflecting the continued recovery in the Gaming division, good momentum in Densitron and resilient supply chain management. The Group enters the second half of 2022 with an order book which gives good visibility of full year trading. Despite inflationary pressures, we now expect revenue and profit to be ahead of market expectations1.

 

Notice of Results

The Board expects to announce its results for the six months ended 30 June 2022 on 6 September 2022.

 

Jon Jayal, CEO of Quixant, commented: "It is extremely pleasing to report such strong trading in the first half of the year giving us confidence in ongoing growth, underpinned by buoyant order intake. The business has risen to the ongoing challenges presented by the electronic component market shortages and worked tirelessly with all stakeholders to mitigate the effects on our customers. We enter the second half of the year with confidence of continued strength in trading and therefore expect full year revenues and profit to be ahead of market expectations1. "

 

1 The current range of forecasts for the year ended 31 December 2022 is revenue of between $95.5m and $95.8m with a consensus of $95.7m and adjusted profit before tax of $7.8m.

 

 

Quixant plc

Jon Jayal, Chief Executive Officer

Johan Olivier, Chief Financial Officer

 

 

Tel: +44 (0)1223 892 696

Nominated Adviser and Broker:

finnCap Ltd

Matt Goode / Simon Hicks (Corporate Finance)

Alice Lane / Charlotte Sutcliffe (ECM)

 

 

Tel: +44 (0) 20 7220 0500

Joint Broker:

Canaccord Genuity Limited

Simon Bridges / Andrew Potts

 

 

Tel: +44 (0) 20 7523 8000

Financial PR:

Alma PR

John Coles / Hilary Buchanan / Kieran Breheny

Tel: +44 (0)20 3405 0205

 

About Quixant

Quixant, founded in 2005, designs and manufactures highly optimised computing solutions and monitors principally for the global gaming and broadcast industries. The Company is headquartered in Cambridge in the UK, with offices throughout Europe, North America and Asia. Quixant has its own manufacturing and engineering operation based in Taiwan and software engineering and customer support teams based in Italy and Slovenia. All the specialised products software and manufacturing are produced in-house and Quixant owns all its own IP some of which is protected by patents and design rights.

In November 2015 Quixant acquired Densitron Technologies plc. Densitron has a strong heritage in the sale of electronic display solutions to global industrial markets. Through Densitron's experienced sales team, Quixant has a robust platform to build its business into wider industrial markets. In-depth information on the Company's products, markets, activities and history can be found on the corporate website at www.quixant.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTKZGMNKFRGZZM
Date   Source Headline
10th Dec 20209:00 amRNSPrice Monitoring Extension
10th Dec 20207:00 amRNSTrading Update
17th Nov 20205:52 pmRNSHolding(s) in Company
27th Oct 20207:00 amRNSExercise of Options
14th Oct 20206:15 pmRNSHolding(s) in Company
13th Oct 20207:00 amRNSDirector Shareholding
12th Oct 20203:17 pmRNSGrant of Options
7th Oct 20205:26 pmRNSHolding(s) in Company
30th Sep 20207:00 amRNSInterim Results
19th Aug 20207:00 amRNSAppointment of Interim CFO
10th Aug 20207:00 amRNSChanges to the Board of Directors
23rd Jul 20204:45 pmRNSHolding(s) in Company
23rd Jul 20204:05 pmRNSHolding(s) in Company
22nd Jul 20207:00 amRNSTrading Update and Notice of Results
3rd Jul 20205:57 pmRNSHolding(s) in Company
3rd Jul 20205:57 pmRNSHolding(s) in Company
19th May 20204:21 pmRNSResult of AGM
19th May 20207:00 amRNSTrading Update
6th May 20204:41 pmRNSSecond Price Monitoring Extn
6th May 20204:35 pmRNSPrice Monitoring Extension
29th Apr 20204:42 pmRNSSecond Price Monitoring Extn
29th Apr 20204:36 pmRNSPrice Monitoring Extension
28th Apr 20207:00 amRNSDirector/PDMR Shareholding
27th Apr 20207:00 amRNSDesignate Director Shareholding
23rd Apr 20207:00 amRNSAppointment of Non-Executive Director
6th Apr 20207:00 amRNSAudited Final Results
3rd Apr 202012:23 pmRNSHolding(s) in Company
31st Mar 20207:00 amRNS2019 Trading and COVID-19 update
27th Mar 20203:08 pmRNSTiming of Results
26th Mar 20204:50 pmRNSBoard Change
19th Mar 202012:50 pmRNSHolding(s) in Company
18th Mar 20207:00 amRNSNotice of Results Update
12th Feb 20205:44 pmRNSHolding(s) in Company
29th Jan 20207:00 amRNSTrading Update and Notice of Results
20th Dec 20195:50 pmRNSHolding(s) in Company
24th Oct 20194:13 pmRNSDirector/PDMR Shareholding
22nd Oct 20193:05 pmRNSHolding(s) in Company
22nd Oct 20193:05 pmRNSHolding(s) in Company
14th Oct 20194:10 pmRNSDirector/PDMR Shareholding
7th Oct 20195:14 pmRNSDirector/PDMR Transfer Shareholding
27th Sep 20193:41 pmRNSHolding(s) in Company
23rd Sep 20193:09 pmRNSDirector/PDMR Shareholding
19th Sep 20194:13 pmRNSDirector/PDMR Shareholding
18th Sep 20194:54 pmRNSDirector/PDMR Shareholding
17th Sep 20199:05 amRNSSecond Price Monitoring Extn
17th Sep 20199:00 amRNSPrice Monitoring Extension
17th Sep 20197:00 amRNSInterim Results
23rd Jul 20197:00 amRNSTrading Update and Notice of Results
22nd Jul 201911:54 amRNSExercise of Options
4th Jul 20197:00 amRNSCompany Presentation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.